Actuate Therapeutics (ACTU) Insider Trading & Ownership

$8.10

-0.27 (-3.23%)

(As of 02:19 PM ET)

Current Insider Ownership Percentage: 19.90%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $4 M
Number Of Insiders Selling (Last 12 Months): 2
Amount Of Insider Selling (Last 12 Months): $374,991.00

Get ACTU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACTU Insider Buying and Selling by Quarter

Ad Brownstone Research

My big AI project…

On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.

Just click here to register.

Actuate Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/14/2024	Equity Cof Lp Bios	Director	Buy	500,000	$8.00	$4,000,000.00
8/14/2024	Leslie W Kreis	Major Shareholder	Sell	24,999	$9.00	$224,991.00
8/14/2024	Todd S Thomson	Insider	Sell	18,750	$8.00	$150,000.00

(Data available from 1/1/2013 forward)

ACTU Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Actuate Therapeutics includes Equity Cof Lp Bios, Leslie W Kreis, and Todd S Thomson. Learn more on insiders at ACTU.
: 19.90% of Actuate Therapeutics stock is owned by insiders. Learn more on ACTU's insider holdings.
: The following insider purchased ACTU shares in the last 24 months: Equity Cof Lp Bios ($4,000,000.00).
: Insiders have purchased a total of 500,000 ACTU shares in the last 24 months for a total of $4,000,000.00 bought.
: The following insiders have sold ACTU shares in the last 24 months: Leslie W Kreis ($224,991.00), and Todd S Thomson ($150,000.00).
: Insiders have sold a total of 43,749 Actuate Therapeutics shares in the last 24 months for a total of $374,991.00 sold.

Actuate Therapeutics Key Executives

Mr. Daniel M. Schmitt (Age 62)
CEO, President & Director
Compensation: $520k
Dr. Andrew P. Mazar Ph.D. (Age 62)
Co-Founder & COO
Compensation: $607.5k
Dr. Alan Kozikowski Ph.D. (Age 73)
Scientific Founder and Advisor
Mr. Paul J. Lytle CPA (Age 56)
Chief Financial Officer